$5.63
▲ +$0.08
(+1.44%)
Vol 1.8M
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$581.5M
ROE
-146.2%
Margin
-930.2%
D/E
232.06
Beta
0.46
52W
$3–$11
Wall Street Consensus
15 analysts · Apr 20265
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
93.3%
Buy Rating
Price Chart
Similar Stocks
UPB
Upstream Bio Inc
$1.5B
RIGL
Rigel Pharmaceuticals Inc
P/E 6.9
$777.4M
LRMR
Larimar Therapeutics Inc
$326.1M
TRDA
Entrada Therapeutics Inc
$392.9M
LYEL
Lyell Immunopharma Inc
$653.9M
FDMT
4D Molecular Therapeutics Inc
$428.5M
IMMX
Immix Biopharma Inc
$275.6M
ABSI
Absci Corp
$524.8M
ASMB
Assembly Biosciences Inc
$537.9M
STTK
Shattuck Labs Inc
$231.0M
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.47
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.47 | — | — |
| Dec 2025 | $-0.55 | $-0.50 | +$0.05 |
| Sep 2025 | $-0.65 | $-1.35 | $-0.70 |
| Jun 2025 | $-0.76 | $-0.39 | +$0.37 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -146.2% | -146.2% | -146.2% | -146.2% | -146.2% | -146.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1213.6% | -1213.6% | -1213.6% | -1213.6% | -930.2% | -930.2% |
| Gross Margin | 85.1% | 85.1% | 85.1% | 85.1% | 85.1% | 85.1% |
| D/E Ratio | 232.06 | 232.06 | 232.06 | 232.06 | 232.06 | 232.06 |
| Current Ratio | 3.46 | 3.46 | 3.46 | 3.46 | 2.58 | 2.58 |
Key Ratios
ROA (TTM)
-119.5%
P/S (TTM)
43.46
P/B
2.6
EPS (TTM)
$-3.06
CF/Share
$-3.92
Rev Growth 3Y
+69.6%
52W High
$11.25
52W Low
$3.46
$3.46
52-Week Range
$11.25
How does VSTM compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
VSTM valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
43.5
▲
238%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
2.6
▲
6%
above
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
VSTM profitability vs Biotechnology peers
ROE
-146.2%
▼
117%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-930.2%
▼
224%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
85.1%
▲
8%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-119.5%
▼
156%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
VSTM financial health vs Biotechnology peers
D/E ratio
232.1
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
2.6
▼
42%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.5
▼
53%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
VSTM fundamentals radar
VSTM
Peer median
Industry
VSTM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
VSTM vs peers: key metrics
Latest News
No related news yet